Christine Schultheis is a principal at CRA. She has more than 15 years of life sciences consulting experience encompassing product forecasting, investment due diligence, life cycle planning, market assessment, product opportunity assessment, product positioning, and commercial launch planning and strategy development. As a project manager, Christine has led qualitative and quantitative engagements in life sciences and developed understanding in a variety of therapeutic areas encompassing oncology/hematology, autoimmune disease, metabolic disorders, ophthalmology, neurological disease, infectious disease, and multiple orphan disease areas.
Prior to joining Charles River Associates, Christine was a partner of bioStrategies Group, a firm offering research and analysis in support of commercial strategy decisions to life science companies. Over her career, she also worked as a national accounts manager for a managed care services provider, sales director in physician services.